IMU

9.26%

5.9¢ imugene limited

Ann: Imugene completes $35M Placement & Launches c.$30M SPP, page-336

First 336 Last

Share
Profile

Follow
mrdingo

4,158 Posts.

1180

23/08/23

08:51

Post #: 69492497
Share

Originally posted by Taureanbull: ↑

Bat35Y,

The reason I’m so optimistic, I can clearly see the strategy here! The value and appeal of these assets is growing rapidly. IMU have done an amazing job over the last four years , recreating a mini-Genentech . Obviously that’s LC’s dream. Only she is building something here that is so much better than Genentech. Many posters get lost in the weeds, microanalysing the minute details, without the knowledge or experience to know how it all fits together.

Remember Monil Shah is on the phone dawn till dark talking with other high level players in the onco-world. He would know stuff they we couldn’t dream of knowing. So he was employed to do a job. At this point I have to show trust in his ability. You can bet your last dollar he had a lot of input here.

So I see a game changing company being built at warp speed. IMU has really dressed this company up to be a huge target for Big Pharma. IMU has come from nowhere and jumped the queue in the Allogenic CarT space. This space is red hot. But until now it’s been confined to blood cancers. Just 10% of the market.

Big Pharma will be all over this move by IMU. Monil’s phone will be ringing off the hook.

We now are the cutting edge cancer biotech frontrunner. We are the only company in the world that has all of this tech.

LC clearly stated that we are open to do deals. Whether it’s a trade sale, a partnership or a licence. Or if need be we can still go it alone if we can’t negotiate suitable terms. That’s a last resort. If s very unlikely it will come to that.

But if it does , it’s very near term in Biotech Terms. And once IMU does get a succession registration trial under its belt, the whole world is at their feet. They will have funding to do anything they want.

I can’t believe how many posters can’t see how good this move is. Leslie and Paul must be shaking their heads in disbelief at how stupid most of their shareholders are!

Expand

"recreating a mini-Genentech"
Genentech was a company founded in the 70s. It was acquired 50 years later.... I hope we're not going to take that long....

IMU Price at posting: 6.9¢ Sentiment: Hold Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

There are more pages in this discussion • 119 more messages in this thread...

First 336 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change 0.005(9.26%)		Mkt cap ! $433.6M

Open	High	Low	Value	Volume
5.5¢	5.9¢	5.4¢	$1.489M	25.99M

Buyers (Bids)

No.	Vol.	Price($)
2	35252	5.9¢

Sellers (Offers)

Price($)	Vol.	No.
6.0¢	1753430	24

View Market Depth

No.	Vol.	Price($)
2	717241	0.058
8	1860543	0.057
3	1067860	0.056
20	2643992	0.055
6	1127777	0.054

Price($)	Vol.	No.
0.060	1095176	20
0.061	520305	5
0.062	290000	4
0.063	100000	1
0.064	217000	3

Last trade - 16.10pm 12/07/2024 (20 minute delay)

IMU (ASX) Chart

Ann: Imugene completes $35M Placement & Launches c.$30M SPP, page-336

Immutep reports strong response rate from immunotherapies treating carcinomas

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Imugene completes $35M Placement & Launches c.$30M SPP, page-336

Top Stories

Immutep reports strong response rate from immunotherapies treating carcinomas

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News